Advertisement

Picture ConsulTech GmbH GDPR-compliant E-Col Home Office 650x80px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements in North America, Europe and Israel or involving organisations from these countries.

Total search results: 6952 | Ordered by Date (descending)
1 2 3 ... 68 69 70  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Lava Therapeutics–Bellevue: investment, 202009 financing round Series C totalling $83m incl new + co-investor BB Pureos Bioventures 2020-09-17
Lava Therapeutics–Gilde Investment: investment, 202009 financing round Series C totalling $83m incl existing + co-investor Gilde Healthcare 2020-09-17
Lava Therapeutics–Merck (US): investment, 202009 financing round Series C totalling $83m incl existing + co-investor MRL Ventures Fund LLC 2020-09-17
Lava Therapeutics–Novo Group: investment, 202009 financing round Series C totalling $83m incl new + co-lead investor Novo Ventures 2020-09-17
Lava Therapeutics–Redmile Group: investment, 202009 financing round Series C totalling $83m incl new + co-investor Redmile Biopharma Investments 2020-09-17
Lava Therapeutics–Sanofi: investment, 202009 financing round Series C totalling $83m incl new + co-lead investor Sanofi Ventures 2020-09-17
Lava Therapeutics–SEVERAL: investment, 202009 financing round Series C $83m co-led by Novo Ventures + Sanofi Ventures 2020-09-17
Lava Therapeutics–Versant Ventures: investment, 202009 financing round Series C totalling $83m incl existing + co-investor Versant 2020-09-17
Lava Therapeutics–Ysios Capital: investment, 202009 financing round Series C totalling $83m incl new + co-investor Ysios Capital 2020-09-17
Novartis–BioNTech: investment, 202009– acquisition of Novartis GMP Biologics Manufacturing Site in Marburg by BioNTech 2020-09-17
Dinaqor–KWM Communications: public relations, 202009 service existent by KWM Communications 2020-09-16
Graphite Bio–Samsara BioCapital: investment, 202009 financing round Series A totalling $45m incl co-investor Samsara BioCapital 2020-09-16
Graphite Bio–SEVERAL: investment, 202009 financing round Series A $45m led by founding investor Versant Ventures with Samsara BioCapital 2020-09-16
Graphite Bio–Versant Ventures: investment, 202009 financing round Series A totalling $45m incl founding + lead investor Versant Ventures 2020-09-16
Moderna–Cabinet Privé de Conseils: public relations, 202009 service existent CPC is Swiss media contact 2020-09-16
Neogene Therapeutics–EcoR1 Capital: investment, 202009 financing round Series A totalling $110m incl new + co-lead investor EcorR1 Capital 2020-09-14
Neogene Therapeutics–Jeito Capital: investment, 202009 financing round Series A totalling $110m incl new + co-lead investor Jeito Capital 2020-09-14
Neogene Therapeutics–Polaris Partners: investment, 202009 financing round Series A totalling $110m incl new + co-investor Polaris Partners 2020-09-14
Neogene Therapeutics–Pontifax: investment, 202009 financing round Series A totalling $110m incl new + co-investor Pontifax 2020-09-14
Neogene Therapeutics–SEVERAL: investment, 202009 financing round Series A $110m co-led by EcorR1 Capital + Jeito Capital + Syncona 2020-09-14
Neogene Therapeutics–Syncona: investment, 202009 financing round Series A totalling $110m incl new + co-lead investor Syncona 2020-09-14
Neogene Therapeutics–Texas Pacific Group: investment, 202009 financing round Series A totalling $110m incl existing + co-investor TPG 2020-09-14
Neogene Therapeutics–Two River: investment, 202009 financing round Series A totalling $110m incl existing + co-investor Two River 2020-09-14
Neogene Therapeutics–Vida Ventures: investment, 202009 financing round Series A totalling $110m incl existing + co-investor Vida Ventures 2020-09-14
Canopy Biosciences–Bruker: investment, 202009 acquisition €na of Canopy Biosciences LLC by Bruker Corp 2020-09-11
Korro Bio–Alexandria Real Estate: investment, 202009 financing round Series A totalling $91.5m incl new + co-investor Alexandria Venture Investments 2020-09-10
Korro Bio–Atlas Venture: investment, 202009 financing round Series A totalling $91.5m incl existing + co-investor Atlas Venture 2020-09-10
Korro Bio–Citadel: investment, 202009 financing round Series A totalling $91.5m incl new + co-investor Surveyor Capital 2020-09-10
Korro Bio–Cormorant Asset Management: investment, 202009 financing round Series A totalling $91.5m incl new + co-investor Cormorant 2020-09-10
Korro Bio–Mitsubishi Chemical: investment, 202009 financing round Series A totalling $91.5m incl new + co-investor MP Healthcare Venture Management 2020-09-10
Korro Bio–New Enterprise Associates: investment, 202009 financing round Series A totalling $91.5m incl existing + co-investor NEA 2020-09-10
Korro Bio–Qiming: investment, 202009 financing round Series A totalling $91.5m incl new + co-investor Qiming Venture Partners USA 2020-09-10
Korro Bio–SEVERAL: investment, 202009 financing round Series A $91.5m led by Wu Capital 2020-09-10
Korro Bio–Ten Bridge Communications: public relations, 202008 service existent by Ten Bridge 2020-09-10
Korro Bio–Wu Capital: investment, 202009 financing round Series A totalling $91.5m incl new + lead investor Wu Capital 2020-09-10
Oncomfort–SEVERAL: investment, 202009 financing round Series A €10m co-led by Debiopharm + Crédit Mutuel Innovation 2020-09-09
United States (govt)–Intravacc: EV D68 vaccine, 202009– co-development contract up to $9.4m for prophylactic enterovirus D68 vaccine with NIAID 2020-09-08
Boehringer–BiomX: biomarker discovery, 202009– collab discovery of microbiome-based biomarkers for IBD using XMarker platform 2020-09-02
Switzerland (govt)–Moderna: mRNA-based vaccines, 202009c– contract for supply of 4.5m doses of Covid-19 vaccine candidate mRNA-1273 2020-09-01
Aimmune Therapeutics–Nestlé: investment, 202008– cash tender offer for all remaining shares at $34.5/share representing total equity value of $2.6b 2020-08-31
Entasis Therapeutics–Innoviva: investment, 202008 private placement totalling $25m incl Innoviva + another institutional investor 2020-08-28
Entasis Therapeutics–OTHER: investment, 202008 private placement totalling $25m incl Innoviva + another institutional investor 2020-08-28
Entasis Therapeutics–Ruth Group: public relations, 202008 service existent by The Ruth Group 2020-08-28
Entasis Therapeutics–SEVERAL: investment, 202008 private placement $25m with 9.346m units at $2.675 to Innoviva + another institutional investor 2020-08-28
Intact Vascular–Philips: investment, 202008– acquisition $275m upfront + $85m at closing of transaction 2020-08-27
Triumvira Immunologics–Bayer: investment, 202008 financing round Series A totalling $55m incl new + co-lead investor Leaps by Bayer 2020-08-27
Triumvira Immunologics–Northpond Ventures: investment, 202008 financing round Series A totalling $55m incl new + co-lead investor Northpond Ventures 2020-08-27
Triumvira Immunologics–Oceanpine Capital: investment, 202008 financing round Series A totalling $55m incl new + co-investor Oceanpine Capital 2020-08-27
Triumvira Immunologics–SEVERAL: investment, 202008 financing round Series A $55m co-led by Leaps by Bayer + Northpond Ventures 2020-08-27
Triumvira Immunologics–Viva Biotech: investment, 202008 financing round Series A totalling $55m incl new + co-investor Viva Biotech Holdings 2020-08-27
Freenome–SEVERAL: investment, 202008 financing round Series C $270m co-led by Bain Capital Life Sciences + Perceptive Advisors 2020-08-26
NewAmsterdam Pharma–Forbion: investment, 202008 seed financing round totalling €20m from Forbion + founders 2020-08-25
NewAmsterdam Pharma–McDougall Communications: public relations, 202008 service existent by McDougall 2020-08-25
NewAmsterdam Pharma–SEVERAL: investment, 202008 seed financing round €20m from Forbion + founders 2020-08-25
Takeda–Engitix: antifibrotics, 202008– collab + license agreem up to $500m+ developm for advanced liver diseases incl NASH 2020-08-25
Univ Guelph–Bruker: NMR spectrometer, 202008 supply existent of 400 MHz NMR spectrometer + Fourier 80 benchtop NRM system 2020-08-24
Kymera Therapeutics–SEVERAL: investment, 202008 IPO $173.7m+$26.1m with 8.7m+1.3m common shares at $20/share at Nasdaq Global Market 2020-08-20
Kymera Therapeutics–Verge Scientific Communications: public relations, 202008 service existent by Verge 2020-08-20
Scienion–Cellink: investment, 202008– acquisition €80m on cash/debt-free basis with €40m in shares + €40m in shares 2020-08-19
CureVac–Hopp Group: investment, 202008 private placement €100m at $16/share to DH-LT-Investments GmbH + affiliates 2020-08-18
Mobilion–SEVERAL: investment, 202008 financing round Series B $35m led by aMoon + incl Agilent + IP Group + Hostplus + Cultivation Capital 2020-08-17
Principia Biopharma–Sanofi: investment, 202008– acquisition $3.68b cash tender offer at $100/share 2020-08-17
F2G Ltd–Cowen: investment, 202008 financing round totalling $60.8m incl new investor Cowen Healthcare Investments 2020-08-12
F2G Ltd–SEVERAL: investment, 202008 financing round $60.8m from new investor Cowen Healthcare Investments + existing investors 2020-08-12
Galapagos–Scipher Medicine: AI-based drug discovery, 202008– collab IBD drug target valuation with excl option rights for developm for Galapagos 2020-08-12
Atomwise–AME Cloud Ventures: investment, 202008 financing round Series B totalling $123m incl existing + co-investor AME Cloud Ventures 2020-08-11
Atomwise–B Capital Group: investment, 202008 financing round Series B totalling $123m incl co-lead investor B Capital Group 2020-08-11
Atomwise–BV: investment, 202008 financing round Series B totalling $123m incl existing + co-investor BV 2020-08-11
Atomwise–DCVC: investment, 202008 financing round Series B totalling $123m incl existing + co-investor DCVC 2020-08-11
Atomwise–Dolby Family Ventures: investment, 202008 financing round Series B totalling $123m incl existing + co-investor Dolby Family Ventures 2020-08-11
Atomwise–OTHER: investment, 202008 financing round Series B totalling $123m incl two top ten global insurance companies as new investors 2020-08-11
Atomwise–Sanabil Investments: investment, 202008 financing round Series B totalling $123m incl co-lead investor Sanabil 2020-08-11
Atomwise–SEVERAL: investment, 202008 financing round Series B $123m co-led by B Capital Group + Sanabil Investments 2020-08-11
Atomwise–Tencent: investment, 202008 financing round Series B totalling $123m incl existing + co-investor Tencent 2020-08-11
Atomwise–Y Combinator: investment, 202008 financing round Series B totalling $123m incl existing + co-investor Y Combinator 2020-08-11
Bayer–Atomwise: AI-based drug discovery, 202008 collab existent 2020-08-11
Bayer–Linklaters: legal services, 202008 supply service legal counsel with regard to acquisition of Kandy Therapeutics by Bayer 2020-08-11
Bayer–Morgan Stanley: financial services, 202008 supply service financial advisor with regard to acquisition of Kandy Therapeutics by Bayer 2020-08-11
Bridge Biotherapeutics–Atomwise: AI-based drug discovery, 202008 collab existent 2020-08-11
Kandy Therapeutics–Goldman Sachs: financial services, 202008 supply service financial advisor with regard to acquisition of Kandy Tx by Bayer 2020-08-11
Kandy Therapeutics–Goodwin Procter: legal services, 202008 supply service legal counsel with regard to acquisition of Kandy Therapeutics by Bayer 2020-08-11
Stemonix–Atomwise: AI-based drug discovery, 202008 collab existent 2020-08-11
Theia Biosciences–Atomwise: AI-based drug discovery, 202008 collab existent joint venture 2020-08-11
Vairus–Atomwise: AI-based drug discovery, 202008 collab existent joint venture 2020-08-11
X-37–Atomwise: AI-based drug discovery, 202008 collab existent joint venture 2020-08-11
CureVac–SEVERAL: investment, 202008 IPO $245.3m with 13.3m+2m common shares at $16/share at Nasdaq Global Market 2020-08-10
Dyne Therapeutics–Atlas Venture: investment, 202008 financing round totalling $115m incl existing + co-investor Atlas Venture 2020-08-10
Dyne Therapeutics–Citadel: investment, 202008 financing round totalling $115m incl new + co-lead investor Surveyor Capital 2020-08-10
Dyne Therapeutics–Forbion: investment, 202008 financing round totalling $115m incl existing + co-investor Forbion 2020-08-10
Dyne Therapeutics–Franklin Templeton: investment, 202008 financing round totalling $115m incl new + co-investor Franklin Templeton 2020-08-10
Dyne Therapeutics–Logos Capital: investment, 202008 financing round totalling $115m incl new + co-investor Logos Capital 2020-08-10
Dyne Therapeutics–MPM Capital: investment, 202008 financing round totalling $115m incl existing + co-investor MPM Capital 2020-08-10
Dyne Therapeutics–OTHER: investment, 202008 financing round totalling $115m incl new undisclosed institutional co-investor 2020-08-10
Dyne Therapeutics–SEVERAL: investment, 202008 financing round $115m co-led by new investors Vida Ventures + Surveyor Capital 2020-08-10
Dyne Therapeutics–Vida Ventures: investment, 202008 financing round totalling $115m incl new + co-lead investor Vida Ventures 2020-08-10
Dyne Therapeutics–Wellington Management: investment, 202008 financing round totalling $115m incl new + co-investor Wellington Management Company 2020-08-10
Immunic–SEVERAL: investment, 202008 underwritten public offering $90m+$13.5m with 5m+750k shares common stock at $18/share 2020-08-10
Pfenex–Ligand: investment, 202008– cash tender offer $438m upfront at $12/share + $78 CVR milestone ANNOUNCED 2020-08-10
T-Knife–Andera Partners: investment, 202008 financing round Series A totalling €66m incl existing + co-investor Andera Partners 2020-08-06
T-Knife–Boehringer: investment, 202008 financing round Series A totalling €66m incl existing + co-investor BIVF 2020-08-06
1 2 3 ... 68 69 70  next pagenext page



Advertisement

Picture EBD Group BIO-Europe 2020 Digital Event BEU2020 650x81

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px

» top